Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.20 +0.03 (+2.56%)
At close: Sep 30, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Prepaid Assets (2023 - 2026)

Updated

Telomir Pharmaceuticals (TELO) reported Prepaid Assets of $195,618 for Q2 2026, up 159.8% from $75,288 a year earlier.

Analysis

Telomir Pharmaceuticals (TELO) Prepaid Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Telomir Pharmaceuticals posted Prepaid Assets of $54,691, down 5.5% from FY2024.

  • By year, Prepaid Assets came in at $57,874 in FY2024 and $713.00 in FY2023.
  • The Q2 2026 figure ranks as the highest quarterly Prepaid Assets in data going back to Q4 2023.
  • Year over year, Prepaid Assets gained in 1 of the last five quarters, with growth averaging 24.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Telomir Pharmaceuticals 82.53 Mn 82.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 195,618.00
Dec 31, 2025 54,691.00
Sep 30, 2025 72,819.00
Jun 30, 2025 75,288.00
Mar 31, 2025 88,189.00
Dec 31, 2024 57,874.00
Sep 30, 2024 77,347.00
Jun 30, 2024 87,813.00
Mar 31, 2024 98,808.00
Dec 31, 2023 713.00
API Access

Telomir Pharmaceuticals Prepaid Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=prepaid-assets&ticker=TELO&period=max&api_key=YOUR_API_KEY